Articles with public access mandates - Satoru OsukaLearn more
Available somewhere: 15
Intertumoral heterogeneity within medulloblastoma subgroups
FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ...
Cancer cell 31 (6), 737-754. e6, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Overcoming therapeutic resistance in glioblastoma: the way forward
S Osuka, EG Van Meir
The Journal of clinical investigation 127 (2), 415-426, 2017
Mandates: US National Institutes of Health
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ...
The lancet oncology 17 (4), 484-495, 2016
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis
V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ...
Journal of clinical oncology 34 (21), 2468-2477, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
IL-36γ signaling controls the induced regulatory T cell–Th9 cell balance via NFκB activation and STAT transcription factors
A Harusato, H Abo, VL Ngo, SW Yi, K Mitsutake, S Osuka, JE Kohlmeier, ...
Mucosal immunology 10 (6), 1455-1467, 2017
Mandates: US National Institutes of Health
N-cadherin upregulation mediates adaptive radioresistance in glioblastoma
S Osuka, D Zhu, Z Zhang, C Li, CT Stackhouse, O Sampetrean, JJ Olson, ...
The Journal of clinical investigation 131 (6), 2021
Mandates: US Department of Defense, US National Institutes of Health
BAI1 suppresses medulloblastoma formation by protecting p53 from Mdm2-mediated degradation
D Zhu, S Osuka, Z Zhang, ZR Reichert, L Yang, Y Kanemura, Y Jiang, ...
Cancer cell 33 (6), 1004-1016. e5, 2018
Mandates: US National Institutes of Health
Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma
L Dong, S You, Q Zhang, S Osuka, NS Devi, S Kaluz, JH Ferguson, ...
Clinical Cancer Research 25 (7), 2206-2218, 2019
Mandates: US National Institutes of Health, National Natural Science Foundation of …
Early-life microbiota exposure restricts myeloid-derived suppressor cell–driven colonic tumorigenesis
A Harusato, E Viennois, L Etienne-Mesmin, S Matsuyama, H Abo, ...
Cancer immunology research 7 (4), 544-551, 2019
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth
S Kaluz, Q Zhang, Y Kuranaga, H Yang, S Osuka, D Bhattacharya, ...
Oncogene 40 (33), 5182-5191, 2021
Mandates: US National Institutes of Health, National Natural Science Foundation of …
Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of …
M Yamaguchi, S Osuka, O Hankinson, T Murata
International journal of oncology 54 (1), 188-198, 2019
Mandates: US National Institutes of Health
Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic
BK Estep, CJ Kuhlmann, S Osuka, GW Suryavanshi, Y Nagaoka-Kamata, ...
IScience 25 (12), 2022
Mandates: US National Institutes of Health
Epigenetic upregulation of Schlafen11 renders WNT-and SHH-activated medulloblastomas sensitive to cisplatin
S Nakata, J Murai, M Okada, H Takahashi, TH Findlay, K Malebranche, ...
Neuro-oncology 25 (5), 899-912, 2023
Mandates: US National Institutes of Health
A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis
SH Lee, F Khwaja Rehman, KC Tyler, B Yu, Z Zhang, S Osuka, A Zerrouqi, ...
Clinical Cancer Research 26 (11), 2711-2724, 2020
Mandates: US National Science Foundation, US National Institutes of Health
Viral particle-mediated SAMHD1 depletion sensitizes refractory glioblastoma to DNA-damaging therapeutics by impairing homologous recombination
W Daddacha, D Monroe, K Carver, ER Usoro, A Alptekin, H Xu, S Osuka, ...
Cancers 14 (18), 4490, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program